Principal Scientist with 15+ years of expertise in Medicinal Chemistry, specializing in Macrocycles and Small Molecules. Experienced in IND-stage drug discovery, IP & patents, CRO management, and NIH-funded projects. Recognized for contributions in Oncology and Antiviral research, and consulting for Biotech innovation.
years of experience
Multiple Drug Discovery Projects
Experienced medicinal chemist with over 18 years in drug discovery, specializing in small molecules and macrocycles. Proven expertise in structure-based design and IP creation. Skilled in leading multidisciplinary teams and managing complex projects, resulting in NIH grants, publications, and patents. Effective communicator and strategic thinker dedicated to advancing innovative science and delivering stakeholder value.
Building robust preclinical discovery pipelines and identifying multiple drug candidates.
Leveraging computational methods to enhance medicinal chemistry workflows and drug optimization.
With extensive expertise in patent filing and intellectual property management, I excel in analytical data interpretation using HPLC, NMR, and LC-MS techniques. I am skilled in chiral small molecules and macrocycle synthesis, synthetic route scouting and troubleshooting, and integrating cheminformatics with AI/ML approaches. My experience spans hit-to-lead and lead optimization, designing and optimizing small molecules, and leading projects with full-time employees at CROs. I possess strong SAR analysis capabilities and knowledge of DMPK, along with cross-functional communication skills. Notably, I led the COVID protease inhibitor program to preclinical candidate selection, secured two NIH grants for innovative preclinical research, published 13 peer-reviewed articles on medicinal chemistry, developed novel synthetic routes for drug optimization, achieved four issued patents in drug discovery, and advanced several molecules from discovery to IND-enabling studies.
Mighty Machines, Efficient Chemical Manufacturing Enabled by Continuous Technology, SCIENTIFIC UPDATE LTD. (2020). Advanced NMR certification, EMORY UNIVERSITY NUCLEAR MAGNETIC RESONANCE CENTER (2019). SciPhD Certificate Program, SCIPHD.COM (2016).
Thesis: Synthesis of Small Molecule Therapeutics Utilizing Rhodium Carbenoid Chemistry. Advanced research in drug discovery and medicinal chemistry.
Doctoral research in organic chemistry before transferring to Emory to complete the PhD in Medicinal Chemistry.
Initial doctoral studies in organic chemistry with focus on synthesis and mechanistic pathways before transitioning academic programs.
Specialized in advanced organic chemistry with strong foundation in synthesis, reaction mechanisms, and chemical research methodologies.
Studied Chemistry and Industrial Microbiology, establishing a strong academic base for future research in medicinal chemistry.